The nuclear medication section of the University Healthcare facility of Nancy, also selected for four analysis projects relevant to diseases other than most cancers, has just acquired funding beneath a contact for projects in oncology. Led by Pr Antoine Verger, the KING (Kinetic glioma) study so enhances the unique medical investigation hospital software identified as PHRC-K.
Head of the Nancy Delegation for Clinical Exploration and Innovation (DRCI), supported by the Nancyclotep preclinical and scientific study and improvement platform in the field of positron emission tomography (PET) which provides collectively the Nancy CHRU and the University Lorraine, and involving the anatomopathology, neuro-oncology and neurosurgery groups of the University Medical center of Nancy, this examine also incorporates eleven French hospitals. Led by Antoine Verger, KING focuses especially on the first diagnosis of …
–
